{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:34:57Z","timestamp":1793392497492,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.euroneuro.2006.04.003","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T03:34:33Z","timestamp":1149651273000},"page":"S109-S118","source":"Crossref","is-referenced-by-count":75,"special_numbering":"S2","title":["Generalized anxiety disorder: A comorbid disease"],"prefix":"10.1016","volume":"16","author":[{"given":"David","family":"Nutt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spilos","family":"Argyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Potokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2006.04.003_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0010-440X(93)90014-U","article-title":"Causes of death among 936 elderly patients with \u2018pure\u2019 anxiety neurosis in Stockholm County, Sweden, and in patients with depressive neurosis or both diagnoses","volume":"34","author":"Allgulander","year":"1993","journal-title":"Compr. Psychiatry"},{"issue":"Suppl. 15[3]","key":"10.1016\/j.euroneuro.2006.04.003_bib2","first-page":"A21","article-title":"Generalized Anxiety Disorder Inventory (GADI): development and validation of a new questionnaire","author":"Argyropoulos","year":"2001","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.biopsych.2004.07.006","article-title":"Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder","volume":"56","author":"Argyropoulos","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.euroneuro.2006.04.003_bib4","first-page":"20","article-title":"The patient with comorbid depression and anxiety: the unmet need","volume":"60","author":"Bakish","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib5","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0006-3223(99)00220-6","article-title":"Current treatments of the anxiety disorders in adults","volume":"46","author":"Ballenger","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archpsyc.1994.03950040053007","article-title":"Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors","volume":"51","author":"Barr","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0006-3223(96)00224-7","article-title":"Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects","volume":"41","author":"Barr","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0887-6185(03)00031-8","article-title":"Insomnia and generalized anxiety disorder: effects of cognitive behavior therapy for gad on insomnia symptoms","volume":"18","author":"Belanger","year":"2004","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1192\/bjp.178.5.399","article-title":"Tryptophan depletion and its implications for psychiatry","volume":"178","author":"Bell","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/026988110201600116","article-title":"Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine","volume":"16","author":"Bell","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib11","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1590\/S0100-879X2003001000021","article-title":"Headache complaints associated with psychiatric comorbidity in a population-based sample","volume":"36","author":"Bensenor","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/070674379704200904","article-title":"Help-seeking for psychiatric disorders","volume":"42","author":"Bland","year":"1997","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1037\/0022-006X.63.3.479","article-title":"Effects of psychotherapy on comorbid conditions in generalized anxiety disorder","volume":"63","author":"Borkovec","year":"1995","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1176\/ajp.150.8.1216","article-title":"Psychiatric comorbidity in patients with generalized anxiety disorder","volume":"150","author":"Brawman-Mintzer","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/01.PSY.0000097339.75789.81","article-title":"Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment","volume":"65","author":"Brenes","year":"2003","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/da.1070","article-title":"Infrequency of \u201cpure\u201d GAD: impact of psychiatric comorbidity on clinical course","volume":"14","author":"Bruce","year":"2001","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/da.1020","article-title":"One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample","volume":"13","author":"Carter","year":"2001","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3928\/0048-5713-19900901-08","article-title":"Comorbidity in panic disorder","volume":"20","author":"Cassano","year":"1990","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1192\/bjp.176.4.379","article-title":"Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale","volume":"176","author":"Connor","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0006-3223(93)90004-W","article-title":"Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study","volume":"33","author":"De Cristofaro","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0006-3223(99)00014-1","article-title":"Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action","volume":"46","author":"Delgado","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0010-440X(00)90140-8","article-title":"Anxiety disorders in major depression","volume":"41","author":"Fava","year":"2000","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/ajp.151.5.640","article-title":"Epidemiology and comorbidity of anxiety disorders in the elderly","volume":"151","author":"Flint","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000029104","article-title":"Psychiatric comorbidity in Greek patients with generalized anxiety disorder","volume":"32","author":"Garyfallos","year":"1999","journal-title":"Psychopathology"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0010-440X(95)90076-4","article-title":"Comorbidity of anxiety disorders in a multicenter anxiety study","volume":"36","author":"Goisman","year":"1995","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4088\/JCP.v60n0705","article-title":"Mirtazapine in major depression with comorbid generalized anxiety disorder","volume":"60","author":"Goodnick","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1592\/phco.24.6.621.34748","article-title":"Treatment of pain syndromes with venlafaxine","volume":"24","author":"Grothe","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib28","series-title":"Psychiatric Clinics of North America","first-page":"681","article-title":"The neurobiology of anxiety disorders","author":"Johnson","year":"1995"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1212\/WNL.53.3.543","article-title":"Cluster headaches: association with anxiety disorders and memory deficits","volume":"53","author":"Jorge","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1046\/j.1526-4610.2000.00148.x","article-title":"Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes","volume":"40","author":"Juang","year":"2000","journal-title":"Headache"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0447.1998.tb05960.x","article-title":"Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS)","volume":"393","author":"Judd","year":"1998","journal-title":"Acta Psychiatr. Scand., Suppl."},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2006.04.003_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K","article-title":"Comorbidity of mood and anxiety disorders","volume":"12","author":"Kaufman","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-3223(99)00108-0","article-title":"Effects of acute tryptophan depletion on mood in bulimia nervosa","volume":"47","author":"Kaye","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.0065-1591.2000.acp29-02.x","article-title":"The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research","author":"Kessler","year":"2000","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib35","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1176\/ajp.156.12.1915","article-title":"Impairment in pure and comorbid generalized anxiety disorder and major depression at 12\u00a0months in two national surveys","volume":"156","author":"Kessler","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0193-953X(05)70204-5","article-title":"The epidemiology of generalized anxiety disorder","volume":"24","author":"Kessler","year":"2001","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1176\/appi.ajgp.11.3.320","article-title":"Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials","volume":"11","author":"Kimura","year":"2003","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1099-1166(199802)13:2<79::AID-GPS739>3.0.CO;2-G","article-title":"The relationship between anxiety disorders and age","volume":"13","author":"Krasucki","year":"1998","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.euroneuro.2006.04.003_bib39","doi-asserted-by":"crossref","first-page":"S399","DOI":"10.1016\/S0924-977X(99)00051-6","article-title":"Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?","volume":"9","author":"Lader","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1034\/j.1600-0447.2000.101001029.x","article-title":"Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity?","volume":"101","author":"Maier","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archpsyc.55.8.715","article-title":"Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study","volume":"55","author":"Malizia","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000049318","article-title":"Anxiety comorbidity in referred children and adolescents with dysthymic disorder","volume":"34","author":"Masi","year":"2001","journal-title":"Psychopathology"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib43","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/01.chi.0000121065.29744.d3","article-title":"Generalized anxiety disorder in referred children and adolescents","volume":"43","author":"Masi","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib44","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.150.4.600","article-title":"Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder","volume":"150","author":"Massion","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3959(03)00301-4","article-title":"Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample","volume":"106","author":"McWilliams","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0887-6185(00)00026-8","article-title":"Comorbid generalized anxiety disorder in primary social phobia: symptom severity, functional impairment, and treatment response","volume":"14","author":"Mennin","year":"2000","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/smrv.1999.0096","article-title":"Sleep disturbance in generalized anxiety disorder and its treatment","volume":"4","author":"Monti","year":"2000","journal-title":"Sleep Med. Rev."},{"issue":"Suppl. 19","key":"10.1016\/j.euroneuro.2006.04.003_bib48","first-page":"5","article-title":"Dissolving the burden of generalized anxiety disorder","volume":"62","author":"Ninan","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib49","first-page":"261","article-title":"Cerebral glucose metabolic differences in patients with panic disorder","volume":"3","author":"Nordahl","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0193-953X(05)70205-7","article-title":"Comorbidity in generalized anxiety disorder","volume":"24","author":"Noyes","year":"2001","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib51","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/jama.272.22.1741","article-title":"Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care","volume":"272","author":"Ormel","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000066391","article-title":"Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response","volume":"46","author":"Perugi","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004850-200301000-00003","article-title":"Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide","volume":"18","author":"Pini","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291702006906","article-title":"Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly","volume":"33","author":"Porter","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1468-2982.1999.019003159.x","article-title":"Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches","volume":"19","author":"Puca","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib56","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archpsyc.1996.01830050014003","article-title":"A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery","volume":"53","author":"Rauch","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/026988119701100416","article-title":"Rapid depletion of plasma tryptophan: a review of studies and experimental methodology","volume":"11","author":"Reilly","year":"1997","journal-title":"J. Psychopharmacol."},{"issue":"Suppl. 7","key":"10.1016\/j.euroneuro.2006.04.003_bib58","first-page":"86","article-title":"Generalized anxiety and mixed anxiety-depression: association with disability and health care utilization","volume":"57","author":"Roy-Byrne","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib59","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1176\/ajp.150.6.928","article-title":"Diagnostic comorbidity in persons with suicidal ideation and behavior","volume":"150","author":"Rudd","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-1781(94)90036-1","article-title":"Prevalence of personality disorders among patients with anxiety disorders","volume":"51","author":"Sanderson","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib61","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/gps.1001","article-title":"Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study","volume":"18","author":"Schoevers","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib62","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1046\/j.1526-4610.2002.02217.x","article-title":"Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application","volume":"42","author":"Sheftell","year":"2002","journal-title":"Headache"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0165-0327(97)01442-0","article-title":"Course of depression in patients with comorbid anxiety disorders","volume":"43","author":"Sherbourne","year":"1997","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib64","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archpsyc.1996.01830100035005","article-title":"Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers","volume":"53","author":"Sherbourne","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib65","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4088\/JCP.v62n07a04","article-title":"Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder","volume":"62","author":"Silverstone","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib66","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(96)07044-4","article-title":"Relapse of depression after rapid depletion of tryptophan","volume":"349","author":"Smith","year":"1997","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2006.04.003_bib67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-3999(94)90145-7","article-title":"Cost of anxiety disorders: impact of comorbidity","volume":"38","author":"Souetre","year":"1994","journal-title":"J. Psychosom. Res."},{"issue":"Suppl. 11","key":"10.1016\/j.euroneuro.2006.04.003_bib68","first-page":"29","article-title":"Comorbidity in generalized anxiety disorder: impact and implications","volume":"62","author":"Stein","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib69","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0163-8343(00)00080-3","article-title":"Posttraumatic stress disorder in the primary care medical setting","volume":"22","author":"Stein","year":"2000","journal-title":"Gen. Hosp. Psych."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib70","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.mp.4000329","article-title":"Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis","volume":"2","author":"Tiihonen","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib71","first-page":"502","article-title":"An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder","volume":"52","author":"Tollefson","year":"1991","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib72","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0887-6185(98)00020-6","article-title":"The effects of cognitive-behavior therapy for panic disorder on comorbid conditions","volume":"12","author":"Tsao","year":"1998","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0193-953X(05)70210-0","article-title":"Generalized anxiety disorder in children and adolescents","volume":"24","author":"Wagner","year":"2001","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.euroneuro.2006.04.003_bib75","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archpsyc.1994.03950050015002","article-title":"DSM-III-R generalized anxiety disorder in the National Comorbidity Survey","volume":"51","author":"Wittchen","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib74","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004850-200015060-00002","article-title":"Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey","volume":"15","author":"Wittchen","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"Suppl. 8","key":"10.1016\/j.euroneuro.2006.04.003_bib76","first-page":"24","article-title":"Generalized anxiety and depression in primary care: prevalence, recognition, and management","volume":"63","author":"Wittchen","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib77","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0006-3223(91)90326-H","article-title":"PET in generalized anxiety disorder","volume":"29","author":"Wu","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib78","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1192\/bjp.168.3.308","article-title":"Phenomenology and course of generalised anxiety disorder","volume":"168","author":"Yonkers","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib79","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1192\/bjp.176.6.544","article-title":"Factors predicting the clinical course of generalised anxiety disorder","volume":"176","author":"Yonkers","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.04.003_bib80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1468-1331.2003.00551.x","article-title":"Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study","volume":"10","author":"Zwart","year":"2003","journal-title":"Eur. J. Neurol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X0600071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X0600071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T16:59:00Z","timestamp":1683478740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X0600071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":80,"alternative-id":["S0924977X0600071X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2006.04.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}